Cel-Sci Rg
Cel‑SCI Corp, a U.S. clinical‑stage biotech, has Multikine, a Phase‑III immunotherapy for head‑and‑neck cancer, and a patented LEAPS platform that targets infections, autoimmune disorders, and cancer. Its partnership with Saudi Arabian Pharma drives growth.
Headquarters: United States (USA)
- Website: Visit Site 🔗
- Type: Corporation
Company Profile
- Sector: Professional Services
- Industry: Biotechnology Research
- HQ: Vienna
Unlock the full potential.
Upgrade
Get access to Relative P/E Ratio Valuation Histogram.